Measuring the benefits of growth hormone therapy in children: a role for preference-based approaches?
Petrou
Stavros
S
Health Economics Research Centre, Department of Public Health, University of Oxford, Oxford, UK. stavros.petrou@npeu.ox.ac.uk
McIntosh
Emma
E
D002648:Child; D003362:Cost-Benefit Analysis; D006130:Growth Disorders / Q000188:drug therapy*; D019382:Human Growth Hormone / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D017060:Patient Satisfaction; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D016896:Treatment Outcome
D011994:Recombinant Proteins; D019382:Human Growth Hormone